{"items": "14", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "CIO Leadership: The Visionary Leadership Needed to Power New Business Growth Will Drive the Discussion at the 2023 Silicon Valley CIO Executive Leadership Summit on October 17", "url": "https://www.benzinga.com/pressreleases/23/10/g35225945/cio-leadership-the-visionary-leadership-needed-to-power-new-business-growth-will-drive-the-discuss", "time_published": "20231012T172055", "authors": ["Globe Newswire"], "summary": "WESTPORT, Conn., Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to announce that its 2023 Silicon Valley CIO Executive Leadership Summit will be taking place on ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.139354, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SCGLF", "relevance_score": "0.022621", "ticker_sentiment_score": "-0.308137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UPWK", "relevance_score": "0.022621", "ticker_sentiment_score": "0.107583", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRKTF", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXTR", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTG", "relevance_score": "0.045224", "ticker_sentiment_score": "0.083496", "ticker_sentiment_label": "Neutral"}, {"ticker": "S", "relevance_score": "0.022621", "ticker_sentiment_score": "0.085263", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBW", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "APOG", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDX", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBGSF", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNVGF", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRK-A", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWR", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHSCP", "relevance_score": "0.045224", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPB", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.112744", "ticker_sentiment_score": "0.091227", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTNT", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGH", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSD", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZS", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRTC", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLB", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Microsoft To Appeal Against $29B US Tax Claim By IRS, Michael McCaul Calls To Rush Vote For New Speaker - Top Headlines Today While US Was Sleeping", "url": "https://www.benzinga.com/news/23/10/35218906/microsoft-to-appeal-against-29b-us-tax-claim-by-irs-michael-mccaul-calls-to-rush-vote-for-new-speake", "time_published": "20231012T140600", "authors": ["Akanksha Bakshi"], "summary": "Qualcomm, Northrop Grumman And 2 Other Stocks Insiders Are Selling US Stocks Set To Open In Green After 4-Day Winning Streak On Earnings, Fed Pause Hopes - Will Inflation Data Wreck Rally? Red Flag For US Stocks? S&P 500 Valuations Near Dot-Com Boom Levels, Analysis Reveals", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/news.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.027307, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.051663", "ticker_sentiment_score": "0.181515", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.103109", "ticker_sentiment_score": "0.151436", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.160489", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NOC", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.199545", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSLA", "relevance_score": "0.254042", "ticker_sentiment_score": "0.134477", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.051663", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.199545", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.336852", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SONO", "relevance_score": "0.051663", "ticker_sentiment_score": "0.133396", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.154125", "ticker_sentiment_score": "0.086325", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.154125", "ticker_sentiment_score": "0.086325", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:DOGE", "relevance_score": "0.154125", "ticker_sentiment_score": "0.029853", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Stories Thursday, Oct 12: ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany - Apple  ( NASDAQ:AAPL ) , ARM Holdings  ( NASDAQ:ARM ) ", "url": "https://www.benzinga.com/news/23/10/35220687/chatgpt-parent-openai-aims-at-budget-friendly-ai-innovations-novo-nordisks-popular-diabetes-drug-oze", "time_published": "20231012T135217", "authors": ["Vandana Singh"], "summary": "In a surprising turn of events, Apple Inc AAPL and its key suppliers in Taiwan are facing a significant sales slump despite the recent launch of the new iPhone and various Android devices.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/openai-avatar.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.999996"}], "overall_sentiment_score": 0.084268, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DMPZF", "relevance_score": "0.048523", "ticker_sentiment_score": "-0.21396", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.096866", "ticker_sentiment_score": "0.027156", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.144853", "ticker_sentiment_score": "-0.13336", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.144853", "ticker_sentiment_score": "-0.022868", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFY", "relevance_score": "0.144853", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARM", "relevance_score": "0.096866", "ticker_sentiment_score": "0.085914", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.144853", "ticker_sentiment_score": "0.163127", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OPGN", "relevance_score": "0.144853", "ticker_sentiment_score": "0.226056", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DAL", "relevance_score": "0.144853", "ticker_sentiment_score": "0.046024", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.096866", "ticker_sentiment_score": "-0.227756", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSM", "relevance_score": "0.096866", "ticker_sentiment_score": "-0.093282", "ticker_sentiment_label": "Neutral"}]}, {"title": "Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition's Fate Amid Antitrust Pressure - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/10/35216323/will-illumina-give-up-cancer-test-maker-grail-mulls-8b-acquisitions-fate-amid-antitrust-pressure", "time_published": "20231012T113814", "authors": ["Vandana Singh"], "summary": "Illumina Inc ILMN reportedly said it will divest its controversial acquisition of Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or European courts.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.068841, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.953183", "ticker_sentiment_score": "0.201941", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail", "url": "https://apnews.com/article/illumina-grail-eu-antitrust-order-5ffd8038660dd12b17bc4895dc0142e3", "time_published": "20231012T110100", "authors": ["RAF CASERT"], "summary": "BRUSSELS ( AP ) - The European Union on Thursday ordered U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators in the 27-nation bloc.", "banner_image": "https://dims.apnews.com/dims4/default/c46cc36/2147483647/strip/true/crop/5795x3860+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fc6%2Fa4%2Fa65f9a39aed314f47d9f9316eac4%2F4d7a87e7a27d4d759c49f2a8a6ca3d78", "source": "Associated Press", "category_within_source": "Business", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.026548, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.827318", "ticker_sentiment_score": "-0.016467", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina ordered by EU antitrust regulators to sell Grail", "url": "https://www.reuters.com/markets/deals/illumina-ordered-by-eu-antitrust-regulators-sell-grail-2023-10-12/", "time_published": "20231012T095809", "authors": ["Foo Yun Chee"], "summary": "BRUSSELS, Oct 12 ( Reuters ) - U.S. genetic testing company Illumina ( ILMN.O ) has been ordered by EU antitrust regulators to sell cancer test maker Grail ( GRAL.O ) after it completed the deal before securing their approval.", "banner_image": "https://s3.amazonaws.com/arc-authors/reuters/667527b5-7241-4d9c-bf23-822c102ec553.png", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.007233, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.100729", "ticker_sentiment_score": "0.07256", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.100729", "ticker_sentiment_score": "0.07256", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.624423", "ticker_sentiment_score": "-0.021917", "ticker_sentiment_label": "Neutral"}]}, {"title": "EU Orders US Biotech Firms To Unwind $7bn Merger", "url": "https://www.barrons.com/news/eu-orders-illumina-to-unwind-7bn-grail-buy-out-dbc7e4c2", "time_published": "20231012T094500", "authors": ["AFP - Agence France Presse"], "summary": "EU Orders Illumina To Unwind $7bn GRAIL ...", "banner_image": "https://asset.barrons.com/barrons/images/afp-metadata-default.jpg", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.195564, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.578355", "ticker_sentiment_score": "-0.339205", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina to divest Grail if it loses final court appeals in US or EU", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-divest-grail-if-it-loses-final-court-appeals-2023-10-11/", "time_published": "20231011T202200", "authors": ["Reuters"], "summary": "Illumina's global headquarters is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo Acquire Licensing Rights Oct 11 ( Reuters ) - Illumina Inc ( ILMN.O ) said on Wednesday it will divest cancer test maker Grail ( GRAL.O ) if the U.S. life sciences company ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/EWNQV3WFCFKSFER657IKKRJMGQ.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.115696, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.570165", "ticker_sentiment_score": "-0.238987", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina to get EU order on Thursday to divest Grail, source says", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-get-eu-order-thursday-divest-grail-source-says-2023-10-10/", "time_published": "20231010T221400", "authors": ["Foo Yun Chee"], "summary": "A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo Acquire Licensing Rights", "banner_image": "https://s3.amazonaws.com/arc-authors/reuters/667527b5-7241-4d9c-bf23-822c102ec553.png", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.007178, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.12165", "ticker_sentiment_score": "0.078027", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.12165", "ticker_sentiment_score": "0.078027", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.716023", "ticker_sentiment_score": "-0.130027", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.12165", "ticker_sentiment_score": "0.172464", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Global Hereditary Testing Market Shows Strong 8.8% CAGR, Driving Demand for Hereditary Disorder Testing Kits", "url": "https://www.benzinga.com/pressreleases/23/10/g35168974/global-hereditary-testing-market-shows-strong-8-8-cagr-driving-demand-for-hereditary-disorder-test", "time_published": "20231010T181500", "authors": ["Globe Newswire"], "summary": "New York, United States, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- Hereditary genes are either transmitted to offspring or inheritable from parents. Hereditary testing examines an individual's genome for specific hereditary variations ( variants ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.125839, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTG", "relevance_score": "0.113776", "ticker_sentiment_score": "0.053031", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.075995", "ticker_sentiment_score": "0.076191", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.03804", "ticker_sentiment_score": "0.131654", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRA", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGT", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "LGND vs. ILMN: Which Stock Should Value Investors Buy Now?", "url": "https://www.zacks.com/stock/news/2163617/lgnd-vs-ilmn-which-stock-should-value-investors-buy-now", "time_published": "20231010T154010", "authors": ["Zacks Equity Research"], "summary": "LGND vs. ILMN: Which Stock Is the Better Value Option?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default166.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.490695, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.546745", "ticker_sentiment_score": "0.507783", "ticker_sentiment_label": "Bullish"}, {"ticker": "LGND", "relevance_score": "0.682689", "ticker_sentiment_score": "0.589633", "ticker_sentiment_label": "Bullish"}]}, {"title": "Home Hardware paints the town with wellness-inspired 'Colour of the Year' palette for World Mental Health Day - Canada NewsWire", "url": "https://www.newswire.ca/news-releases/home-hardware-paints-the-town-with-wellness-inspired-colour-of-the-year-palette-for-world-mental-health-day-881816268.html", "time_published": "20231010T125600", "authors": [], "summary": "Home Hardware paints the town with wellness-inspired 'Colour of the Year' palette for World Mental Health Day Canada ...", "banner_image": null, "source": "Canada Newswire", "category_within_source": "n/a", "source_domain": "www.newswire.ca", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.33101, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.107495", "ticker_sentiment_score": "0.229337", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Israel imposes 'complete siege' on Gaza", "url": "https://www.ft.com/content/0f617926-dbe0-4bf5-817f-a8b79b9f03ac", "time_published": "20231010T040236", "authors": [], "summary": "This is an audio transcript of the FT News Briefing podcast episode: 'Israel imposes \"complete siege\" on Gaza' Good morning from the Financial Times. Today is Tuesday, October 10th, and this is your FT News Briefing. Israel is retaliating for a violent attack over the weekend.", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fc500be65-5078-4d74-9ca3-2ba3b9350c6c.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1", "source": "Financial Times", "category_within_source": "GoogleRSS", "source_domain": "www.ft.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Economy - Fiscal", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.050921, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.168295", "ticker_sentiment_score": "-0.146659", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.028254", "ticker_sentiment_score": "-0.134834", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.056474", "ticker_sentiment_score": "-0.127227", "ticker_sentiment_label": "Neutral"}]}, {"title": "Israel imposes 'complete siege' on Gaza", "url": "https://www.ft.com/content/5eb3ab0c-4074-4019-a4a4-2703c3d2d56a", "time_published": "20231010T040025", "authors": [], "summary": "Israel imposed a \"complete siege\" of the Gaza Strip, the Bank of Israel said it planned to sell up to $30bn of dollar reserves to support the shekel, and EU regulators will order US biotech Illumina to sell cancer test developer Grail. Israel's central bank to sell $30bn of foreign reserves to ...", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fnext-video-editor-images.s3.ap-northeast-1.amazonaws.com%252Fbe6f3a49-6140-4725-887d-829fa59e5de2%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "source": "Financial Times", "category_within_source": "GoogleRSS", "source_domain": "www.ft.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.011947, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.282234", "ticker_sentiment_score": "-0.252568", "ticker_sentiment_label": "Somewhat-Bearish"}]}]}